Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology ·Vol. 24 ·No. 16 ·2006-06-01 ·Pages 2597-8; author reply 2598-9

Einhorn LH, Foster RS

Abstract

暂无摘要

MeSH Terms

Antineoplastic Combined Chemotherapy Protocols/adverse effects,therapeutic use Bleomycin/administration & dosage Cisplatin/administration & dosage Drug Administration Schedule Etoposide/administration & dosage Humans Male Neoplasms, Germ Cell and Embryonal/drug therapy Risk Assessment Risk Factors

Chemicals

Bleomycin Etoposide Cisplatin

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Einhorn Lawrence H

Foster Richard S

Article Info

Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Abbr.

J Clin Oncol

ISSN

1527-7755

DOI

10.1200/JCO.2006.05.6184

Published

2006-06-01

Pages

2597-8; author reply 2598-9

Language

English

Region

United States

NLM ID

8309333

Subset

Corrections

CommentOn

PMID: 9053482

CommentOn

PMID: 16361627

External Links

PubMed source DOI: 10.1200/JCO.2006.05.6184 View journal details

Analysis Services

Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen?

Contact

WeChat Official Account